James Brockenbrough
Thoracic Surgery (Cardiothoracic Vascular Surgery) Kansas City, KS Medical Doctor
NPI 1932213139 CMS profile 1101640
21 N 12Th St Ste 103A, Kansas City, KS 66102
General payments
$512
Research payments
$0
Ownership & investment interest
$0
Through program year 2020, James Brockenbrough of Kansas City, KS is reported in the CMS Open Payments database as having received $512 across 3 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 18th percentile of Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
2 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2020 | General | $21 | 1 | |
| 2019 | General | $491 | 2 |
Beside peers
- James Brockenbrough
- Thoracic Surgery (Cardiothoracic Vascular Surgery) median
- Middle half of Thoracic Surgery (Cardiothoracic Vascular Surgery)
- National median
In program year 2025, general payments to James Brockenbrough were reported at $0. Among 4,073 Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles paid that year, the median was $791 and the middle half received between $208 and $3,074.
Show as a table
| Year | James Brockenbrough | Thoracic Surgery (Cardiothoracic Vascular Surgery) median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $491 | $886 | $178–$3,167 | $163 |
| 2020 | $21 | $341 | $108–$1,605 | $114 |
| 2021 | $0 | $453 | $125–$1,886 | $132 |
| 2022 | $0 | $695 | $180–$2,566 | $149 |
| 2023 | $0 | $745 | $205–$2,662 | $160 |
| 2024 | $0 | $799 | $214–$2,967 | $164 |
| 2025 | $0 | $791 | $208–$3,074 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 6 drugsPart D claims
78
Drug cost
$1,825
Branded share of claims
53.8%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | Brand | 18 | $583 | |
| Butalbital-Acetaminophen-Caffe Butalb/Acetaminophen/Caffeine | Brand | 11 | $434 | |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | Brand | 13 | $364 | |
| Oxycodone Hcl | Generic | 12 | $257 | |
| Meloxicam | Generic | 11 | $118 | |
| Donepezil Hcl | Generic | 13 | $69 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero.
Records
3 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Thoracic Surgery (Cardiothoracic Vascular Surgery) in Kansas
Keith Allen
Thoracic Surgery (Cardiothoracic Vascular Surgery) · Kansas City, KS
Jessica Heimes
Thoracic Surgery (Cardiothoracic Vascular Surgery) · Kansas City, KS
Matthew Danter
Thoracic Surgery (Cardiothoracic Vascular Surgery) · Kansas City, KS
Emmanuel Daon
Thoracic Surgery (Cardiothoracic Vascular Surgery) · Kansas City, KS
Brett Grizzell
Thoracic Surgery (Cardiothoracic Vascular Surgery) · Wichita, KS
George Zorn
Thoracic Surgery (Cardiothoracic Vascular Surgery) · Kansas City, KS
Related records
Thoracic Surgery (Cardiothoracic Vascular Surgery) in Kansas
Practitioners in the same specialty and state, ranked by reported value.
All Thoracic Surgery (Cardiothoracic Vascular Surgery)
Everyone recorded under this specialty, nationwide.
Doctors in Kansas
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.